BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38898354)

  • 1. Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.
    Albert NL; Preusser M; Traub-Weidinger T; Tolboom N; Law I; Palmer JD; Guedj E; Furtner J; Fraioli F; Huang RY; Johnson DR; Deroose CM; Herrmann K; Vogelbaum M; Chang S; Tonn JC; Weller M; Wen PY; van den Bent MJ; Verger A; Ivanidze J; Galldiks N
    Eur J Nucl Med Mol Imaging; 2024 Jun; ():. PubMed ID: 38898354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [
    Lopci E; Hicks RJ; Dimitrakopoulou-Strauss A; Dercle L; Iravani A; Seban RD; Sachpekidis C; Humbert O; Gheysens O; Glaudemans AWJM; Weber W; Wahl RL; Scott AM; Pandit-Taskar N; Aide N
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2323-2341. PubMed ID: 35376991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [
    Law I; Albert NL; Arbizu J; Boellaard R; Drzezga A; Galldiks N; la Fougère C; Langen KJ; Lopci E; Lowe V; McConathy J; Quick HH; Sattler B; Schuster DM; Tonn JC; Weller M
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):540-557. PubMed ID: 30519867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric
    Vali R; Alessio A; Balza R; Borgwardt L; Bar-Sever Z; Czachowski M; Jehanno N; Kurch L; Pandit-Taskar N; Parisi M; Piccardo A; Seghers V; Shulkin BL; Zucchetta P; Lim R
    J Nucl Med; 2021 Jan; 62(1):99-110. PubMed ID: 33334912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [
    Unterrainer M; Kunte SC; Unterrainer LM; Holzgreve A; Delker A; Lindner S; Beyer L; Brendel M; Kunz WG; Winkelmann M; Cyran CC; Ricke J; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Belka C; Niyazi M; Tonn JC; Bartenstein P; Albert NL
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3390-3399. PubMed ID: 37358620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
    Boursier C; Zaragori T; Bros M; Bordonne M; Melki S; Taillandier L; Blonski M; Roch V; Marie PY; Karcher G; Imbert L; Verger A
    Eur Radiol; 2023 Oct; 33(10):7089-7098. PubMed ID: 37148355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hitherto unknown brain meningioma detected on
    Parghane RV; Talole S; Basu S
    World J Nucl Med; 2019; 18(2):160-170. PubMed ID: 31040748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of [
    Palmisciano P; Watanabe G; Conching A; Ogasawara C; Ferini G; Bin-Alamer O; Haider AS; Sabini MG; Cuttone G; Cosentino S; Ippolito M; Umana GE
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin Receptor Targeted PET-Imaging for Diagnosis, Radiotherapy Planning and Theranostics of Meningiomas: A Systematic Review of the Literature.
    Filippi L; Palumbo I; Bagni O; Schillaci O; Aristei C; Palumbo B
    Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of [
    Milosevic A; Styczen H; Grueneisen J; Li Y; Weber M; Fendler WP; Kirchner J; Damman P; Wrede K; Lazaridis L; Glas M; Guberina M; Eckstein A; Blau T; Herrmann K; Umutlu L; Forsting M; Deuschl C; Schaarschmidt B
    J Nucl Med; 2023 Aug; 64(8):1185-1190. PubMed ID: 37385668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.
    Veit-Haibach P; Ahlström H; Boellaard R; Delgado Bolton RC; Hesse S; Hope T; Huellner MW; Iagaru A; Johnson GB; Kjaer A; Law I; Metser U; Quick HH; Sattler B; Umutlu L; Zaharchuk G; Herrmann K
    Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3513-3537. PubMed ID: 37624384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin Receptor Theranostics for Refractory Meningiomas.
    Salgues B; Graillon T; Horowitz T; Chinot O; Padovani L; Taïeb D; Guedj E
    Curr Oncol; 2022 Aug; 29(8):5550-5565. PubMed ID: 36005176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [
    Piccardo A; Albert NL; Borgwardt L; Fahey FH; Hargrave D; Galldiks N; Jehanno N; Kurch L; Law I; Lim R; Lopci E; Marner L; Morana G; Young Poussaint T; Seghers VJ; Shulkin BL; Warren KE; Traub-Weidinger T; Zucchetta P
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3852-3869. PubMed ID: 35536420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.
    Park S; Parihar AS; Bodei L; Hope TA; Mallak N; Millo C; Prasad K; Wilson D; Zukotynski K; Mittra E
    J Nucl Med; 2021 Oct; 62(10):1323-1329. PubMed ID: 34301785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [
    Ebner R; Lohse A; Fabritius MP; Rübenthaler J; Wängler C; Wängler B; Schirrmacher R; Völter F; Schmid HP; Unterrainer LM; Öcal O; Hinterberger A; Spitzweg C; Auernhammer CJ; Geyer T; Ricke J; Bartenstein P; Holzgreve A; Grawe F
    Eur Radiol; 2024 May; ():. PubMed ID: 38769164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Somatostatin receptor PET/CT (SSTR-PET/CT)].
    Boy C; Poeppel T; Kotzerke J; Krause BJ; Amthauer H; Baum RP; Buchmann I; Ezziddin S; Führer D; Gabriel M; Kuwert T; Lahner H; Lauenstein T; Maecke HR; Nagarajah J; Rösch F; Scheidhauer K; Schmidt M; Walter MA; Bockisch A
    Nuklearmedizin; 2018 Feb; 57(1):4-17. PubMed ID: 29536494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma.
    Müther M; Roll W; Brokinkel B; Zinnhardt B; Sporns PB; Seifert R; Schäfers M; Weckesser M; Stegger L; Stummer W; Rahbar K
    Nuklearmedizin; 2020 Sep; 59(5):348-355. PubMed ID: 32691404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual and whole-body quantitative analyses of
    Hotta M; Sonni I; Thin P; Nguyen K; Gardner L; Ciuca L; Hayrapetian A; Lewis M; Lubin D; Allen-Auerbach M
    Ann Nucl Med; 2024 Apr; 38(4):296-304. PubMed ID: 38252228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiated thyroid cancer: a new perspective with radiolabeled somatostatin analogues for imaging and treatment of patients.
    Versari A; Sollini M; Frasoldati A; Fraternali A; Filice A; Froio A; Asti M; Fioroni F; Cremonini N; Putzer D; Erba PA
    Thyroid; 2014 Apr; 24(4):715-26. PubMed ID: 24102584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Theranostics and hybrid imaging for somatostatin receptor-expressing tumors].
    Werner RA; Bengel FM; Derlin T
    Radiologe; 2020 May; 60(5):413-420. PubMed ID: 32052116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.